Centrus Energy Corp. (NYSE:LEU) is one of the best uranium stocks to buy according to Wall Street analysts.
On May 5, Centrus Energy Corp. (NYSE:LEU) released its Q1 FY2026 financial results where it said it recorded $76.7 million in revenue for the quarter
This figure meant the company missed the analyst estimate of $78.4 million, though it was a 5% year over year increase. Copyright: vencavolrab78 / 123RF Stock Photo The company detailed that income from the Low-Enriched Uranium (LEU) segment, which is its core division, declined 13% year over year to $44.6 million. Management explained that the sales decline was because the volume of separative work units (SWU), which is the key measure of enrichment services, sold dropped 47%, even though average SWU prices rose 52%.
SWU volume is largely contract-driven and lumpy quarter to quarter, so this decline reflects timing rather than lost business, noted management. What offset the LEU decline was a 47% surge in the Technical Solutions segment, Centrus said. This segment’s income grew to $32.1 million from $21.8 million in Q1 2025, which was driven by increasing activity under Centrus’s high-assay, low-enriched uranium, or HALEU, production contract with the US Department of Energy.